Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
Journal
Translational Cancer Research
Journal Volume
8
Pages
S110-S114
Date Issued
2019
Author(s)
SDGs
Other Subjects
antineoplastic agent; axillary lymph node; breast cancer; cancer mortality; cancer radiotherapy; disease free survival; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; human; overall survival; partial mastectomy; postmastectomy radiation therapy; postoperative care; recurrence risk; Review; systemic therapy
Publisher
AME Publishing Company
Type
review